Abstract:<p>Ubiquitin (UB) transfer cascades consisting of E1, E2, and E3 enzymes constitute a complex network that regulates a myriad of biologic processes by modifying protein substrates. Deubiquitinating enzymes (DUBs) reverse UB modifications or trim UB chains of diverse linkages. Additionally, many cellular proteins carry UB-binding domains (UBDs) that translate the signals encoded in UB chains to target proteins for degradation by proteasomes or in autophagosomes, as well as affect nonproteolytic outcomes such as kinase activation, DNA repair, and transcriptional regulation. Dysregulation of the UB transfer pathways and malfunctions of DUBs and UBDs play causative roles in the development of many diseases. A greater understanding of the mechanism of UB chain assembly and the signals encoded in UB chains should aid in our understanding of disease pathogenesis and guide the development of novel therapeutics. The recent flourish of protein-engineering approaches such as unnatural amino acid incorporation, protein semisynthesis by expressed protein ligation, and high throughput selection by phage and yeast cell surface display has generated designer proteins as powerful tools to interrogate cell signaling mediated by protein ubiquitination. In this study, we highlight recent achievements of protein engineering on mapping, probing, and manipulating UB transfer in the cell.</p>Significance Statement<p>The post-translational modification of proteins with ubiquitin alters the fate and function of proteins in diverse ways. Protein engineering is fundamentally transforming research in this area, providing new mechanistic insights and allowing for the exploration of concepts that can potentially be applied to therapeutic intervention.</p>

Engineering cell signaling modulators from native protein-protein interactions.

Palladium-Triggered Deprotection Chemistry for Protein Activation in Living Cells

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Guiding biomolecular interactions in cells using de novo protein-protein interfaces

Protein Engineering in the Ubiquitin System: Tools for Discovery and Beyond

Chemical Engineering of Bacterial Effectors for Regulating Cell Signaling and Responses

Targeted Modulation of E3 Ligases Using Engineered Ubiquitin Variants.

New insights into protein–protein interaction modulators in drug discovery and therapeutic advance

Engineering conditional protein-protein interactions for dynamic cellular control

Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions

Modulators of 14-3-3 Protein–Protein Interactions

Controlling the Subcellular Localization of Signaling Proteins Using Chemically Induced Dimerization and Optogenetics

Recent Developments In Engineering Protein-Protein Interactions Using Phage Display

Exploiting protein domain modularity to enable synthetic control of engineered cells

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

Computational Approaches for the Design of Modulators Targeting Protein-Protein Interactions

Targeting Protein-Protein Interaction by Small Molecules

Protein/peptide secondary structural mimics: design, characterization, and modulation of protein–protein interactions

Protein engineering of gene switches and scissors for human gene therapy

Engineering extrinsic disorder to control protein activity in living cells

Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells.